Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

Kritiya Butthongkomvong1 Udonthani Cancer Hospital, Udonthani, Thailand

Nilubol Raunroadroong2 Lampang Cancer Hospital, Lampang, Thailand

Sirikul Sorrarichingchai2 Lampang Cancer Hospital, Lampang, Thailand

Isaraporn Sangsaikae3 Ubonratchathani Cancer Hospital, Ubonratchathani, Thailand

Vichien Srimuninnimit4 Division of Medical Oncology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Henrik Harling5 Bispebjerg University Hospital, Department of Gastroenterology, Center for Digestive Disease, Copenhagen, Denmark

Stig Larsen6 Digestive Disease Center, Centre for Epidemiology and Biostatistics, Norwegian University of Life Sciences, Oslo, Norway, [email protected]Correspondence[email protected]

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.